Functional Polymer-Based Biomaterials for Corneal Tissue Engineering: An Indication-Guided Review of Design Trade-Offs
- 1, College of Biotechnology and Pharmaceutical Engineering, , Nanjing 211800, China
- 2, , Beijing 100035, China
Abstract
Corneal disease is a cause of vision loss worldwide, while conventional keratoplasty is constrained by limited donor tissue and immune rejection. This indication-guided review examines functional polymer platforms for corneal tissue engineering, including natural polymers, synthetic polymer networks and scaffolds, and hybrid polymer composites. It examines how molecular composition, crosslinking, architecture, surface functionalization, and fabrication influence hydrogels, films, fibrous scaffolds, injectable matrices, delivery systems, and polymeric keratoprosthetic components for epithelial, stromal, and endothelial contexts. Using an indication-guided design trade-off framework, the review compares these systems across optical performance, mechanical performance and surgical handling, mass transport and degradation behavior, biological function and tissue integration, host response, and manufacturability. Natural polymers can provide biological cues that support cell interactions, with limitations in mechanical robustness and compositional consistency. Synthetic polymers offer greater control of network properties and processing but often require biofunctionalization to support tissue integration. Hybrid constructs can distribute optical, structural, and therapeutic functions across components or regions, with added fabrication complexity. No material class is universally optimal, and polymer selection should be guided by the target corneal layer and clinical indication. Standardized evaluation, reproducible reporting of polymer composition and fabrication conditions, scalable manufacturing, and transparent reporting of evidence maturity are priorities for clinical translation.
Related
- Hyaluronic Acid-Based Biomaterials in Tissue Engineering: From Molecular Properties to Re-Generative Applications
- Engineering adaptive polysaccharide biomaterials: integrated biotechnology framework for regenerative medicine
- Intelligence-enabled smart inhalable biomaterials for chronic inflammatory airway diseases: integrating responsive carrier engineering, lung-on-chip validation, and patient-specific pulmonary modeling
- Pathological remodeling and functional evolution of the corneal nervous system in ocular surface dyshomeostasis.
- Engineering Smart Hydrogels Through Dynamic Polymer Networks for Controlled Drug Delivery.
BibTeX
@article{zhang2026functional,
title = {{Functional Polymer-Based Biomaterials for Corneal Tissue Engineering: An Indication-Guided Review of Design Trade-Offs}},
author = {Xinyue Zhang and Ruocheng Zhao and Yang Xu and Lei Sun and Yang Yang and Min Jiang},
journal = {Polymers},
year = {2026},
month = oct,
doi = {10.3390/polym18192420},
url = {https://europepmc.org/article/PMC/PMC13666966},
note = {CC BY},
}
RIS
TY - JOUR
TI - Functional Polymer-Based Biomaterials for Corneal Tissue Engineering: An Indication-Guided Review of Design Trade-Offs
AU - Xinyue Zhang
AU - Ruocheng Zhao
AU - Yang Xu
AU - Lei Sun
AU - Yang Yang
AU - Min Jiang
PY - 2026
DA - 2026/10/01
JO - Polymers
DO - 10.3390/polym18192420
UR - https://europepmc.org/article/PMC/PMC13666966
AB - Corneal disease is a cause of vision loss worldwide, while conventional keratoplasty is constrained by limited donor tissue and immune rejection. This indication-guided review examines functional polymer platforms for corneal tissue engineering, including natural polymers, synthetic polymer networks and scaffolds, and hybrid polymer composites. It examines how molecular composition, crosslinking, architecture, surface functionalization, and fabrication influence hydrogels, films, fibrous scaffolds, injectable matrices, delivery systems, and polymeric keratoprosthetic components for epithelial, stromal, and endothelial contexts. Using an indication-guided design trade-off framework, the review compares these systems across optical performance, mechanical performance and surgical handling, mass transport and degradation behavior, biological function and tissue integration, host response, and manufacturability. Natural polymers can provide biological cues that support cell interactions, with limitations in mechanical robustness and compositional consistency. Synthetic polymers offer greater control of network properties and processing but often require biofunctionalization to support tissue integration. Hybrid constructs can distribute optical, structural, and therapeutic functions across components or regions, with added fabrication complexity. No material class is universally optimal, and polymer selection should be guided by the target corneal layer and clinical indication. Standardized evaluation, reproducible reporting of polymer composition and fabrication conditions, scalable manufacturing, and transparent reporting of evidence maturity are priorities for clinical translation.
SN - 2073-4360
ER -